Literature DB >> 10825596

The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia.

H Qureshi1, B D Gessner, D Leboulleux, H Hasan, S E Alam, L H Moulton.   

Abstract

Over the 33-day duration of the 1999 Haj in Saudi Arabia, we collected daily health status reports for 2070 Pakistani pilgrims over 13 years of age, 54% of whom had elected to receive influenza vaccine immediately before departing for the Haj. We calculated vaccine preventable outcome incidence as the difference in attack rates between vaccinated and unvaccinated persons. The incidences of vaccine preventable influenza-like illness (sore throat in combination with cough or fever of at least 38 degrees C), fever, and any symptom of upper respiratory infection were 22, 17, and 24 per 100 pilgrims per Haj. For every 100 persons who attended the Haj, 17 had a course of antibiotics and 23 had a course of nonprescription cold medication that was preventable with influenza vaccine use. Influenza leads to significant morbidity and medication use among Haj pilgrims. Vaccine against influenza should be considered for pilgrims before entry into Saudi Arabia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825596     DOI: 10.1016/s0264-410x(00)00116-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Acquisition of multidrug-resistant bacteria and encoding genes among French pilgrims during the 2017 and 2018 Hajj.

Authors:  Van-Thuan Hoang; Thi-Loi Dao; Tran Duc Anh Ly; Frédérique Gouriet; Linda Hadjadj; Khadidja Belhouchat; Kamel Larbi Chaht; Saber Yezli; Badriah Alotaibi; Didier Raoult; Philippe Parola; Sophie Alexandra Baron; Vincent Pommier de Santi; Jean-Marc Rolain; Philippe Gautret
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-07       Impact factor: 3.267

Review 2.  Use of vaccines as probes to define disease burden.

Authors:  Daniel R Feikin; J Anthony G Scott; Bradford D Gessner
Journal:  Lancet       Date:  2014-02-17       Impact factor: 79.321

3.  Acceptance and Adverse Effects of H1N1 Vaccinations Among a Cohort of National Guard Health Care Workers during the 2009 Hajj Season.

Authors:  Gasmelseed Y Ahmed; Hanan H Balkhy; Saleh Bafaqeer; Badr Al-Jasir; Abdulhakeem Althaqafi
Journal:  BMC Res Notes       Date:  2011-03-13

4.  Influenza among U.K. pilgrims to hajj, 2003.

Authors:  Haitham El Bashir; Elizabeth Haworth; Maria Zambon; Shuja Shafi; Jane Zuckerman; Robert Booy
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

5.  Population dynamics and tuberculosis: a cross sectional study of an overlooked disease in Saudi Arabia.

Authors:  Jamal Al-Bishri; Ibrahim Masoodi; Mubarki Adnan; Malik Tariq; Harthi Abdullah; Thubaiti Abdulgoni; Guraibi Bander; Mansoor Altalhi
Journal:  Ger Med Sci       Date:  2014-01-15

Review 6.  The Burden of Influenza: a Complex Problem.

Authors:  Aubree Gordon; Arthur Reingold
Journal:  Curr Epidemiol Rep       Date:  2018-02-05

7.  Cardiovascular disease in Hajj pilgrims.

Authors:  Abdullah Al Shimemeri
Journal:  J Saudi Heart Assoc       Date:  2012-02-16

8.  Respiratory Tract Infections and its Preventive Measures among Hajj Pilgrims, 2010: A Nested Case Control Study.

Authors:  Mohammad Hassan Emamian; Ali Mohammad Hassani; Mansooreh Fateh
Journal:  Int J Prev Med       Date:  2013-09

9.  The Saudi Thoracic Society guidelines for influenza vaccinations.

Authors:  Mohammed O Zeitouni; Ali M Al Barrak; Mohamed S Al-Moamary; Nasser S Alharbi; Majdy M Idrees; Abdullah A Al Shimemeri; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

Review 10.  Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review.

Authors:  Siddhivinayak Hirve; Philipp Lambach; John Paget; Katelijn Vandemaele; Julia Fitzner; Wenqing Zhang
Journal:  Influenza Other Respir Viruses       Date:  2016-05-26       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.